Industry experts are excited about what’s on the horizon in surgical robotics in 2025. Speaking on the new season’s first DeviceTalks Tuesdays webinar, advisor Steve Bell — who has more than 25 years of experience in the surgical robotics industry — and The Mullings Group Chair and CEO Joe Mullings joined host Tom Salemi to discuss what’s next for the surgical robotics market, which continues to heat up. Intuitive Surgical, the longtime leader in the space, continues to maintain its pole position in surgical robotics. The company has launched the da Vinci 5, its latest-generation surgical robot, and Bell called the rollout an impressive “textbook launch.” “What I loved about it was they underpromised and then by the numbers they massively over-delivered,” Bell said. “It’s set another new standard. It’s raised the game yet again.” Bell, who will be a keynote speaker at DeviceTalks Boston — April 30–May 1, 2025 — pointed to the system’s broad clearance as a significant factor behind its early success. Mullings added that approval for da Vinci 5 was a given and Intuitive continues to set the standard, saying they’re “just getting started.” “Nobody’s worked closer to the FDA than the Intuitive organization, and it has done a really good job of establishing a baseline and what’s best in class,” Mullings said. “You’re going to see the unleashing of Intuitive as a competitor now.”

Full opinion : How surgical robotics could change the face of biotechnology and healthcare in 2025.